[1]
SARIDOMICHELAKIS (Μ. Ν. ΣΑΡΙΔΟΜΙΧΕΛΑΚΗΣ) N.M., ATHANASIOU (Λ. ΑΘΑΝΑΣΙΟΥ) V.L. and KASABALIS (Δ. ΚΑΣΑΜΠΑΛΗΣ) D. 2017. Is there any place for "second-line" medication in the treatment of canine leishmaniosis? The aminosidine paradigm. Journal of the Hellenic Veterinary Medical Society. 59, 3 (Nov. 2017), 239–246. DOI:https://doi.org/10.12681/jhvms.14961.